Stockreport

Got $2,000? These Biotech Stocks Are Worth Considering for Long-Term Growth [Yahoo! Finance]

Regeneron Pharmaceuticals, Inc.  (REGN) 
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
PDF However, even in this environment, there are excellent biotech stocks to consider buying. These may or may not escape the ongoing volatility, but in the long run, they c [Read more]